Back to Search Start Over

ABCL-362: Incidence, Onset, and Management of Myelosuppression in Patients Treated with loncastuximab Tesirine for R/R DLBCL in a Pooled Safety Analysis.

Authors :
Solh, Melhem
Alderuccio, Juan Pablo
Hess, Brian
Radford, John
Lunning, Matt
Ungar, David
Burke, Muneet
Wang, Luqiang
Ardeshna, Kirit
Source :
Clinical Lymphoma, Myeloma & Leukemia; 2021 Supplement 1, Vol. 21, pS394-S395, 2p
Publication Year :
2021

Details

Language :
English
ISSN :
21522650
Volume :
21
Database :
Complementary Index
Journal :
Clinical Lymphoma, Myeloma & Leukemia
Publication Type :
Academic Journal
Accession number :
152099215
Full Text :
https://doi.org/10.1016/S2152-2650(21)01894-2